MedWatch

Director of Novo's antibiotics fund: Surprisingly few financing opportunities

After one year and four investments, Novo Holdings' Repair Impact Fund is starting to settle in the market, but has also been surprised by the companies' limited access to financing.

Foto: Novo Holdings

Last year, when Novo Holdings first engaged in the fight against antimicrobial resistance, the Danish investment firm was aware of the limited financing opportunities for new companies.

Yet, Aleks Engel, Director of Novo Holdings' new Repair Impact Fund, was taken aback at the poor state of the financing opportunities.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier